Stock CTV INNOVID CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Innovid Corp.

Equities

CTV

US4576791085

End-of-day quote Nyse
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2.34 USD +2.63% Intraday chart for Innovid Corp. +5.88% +56.00%
Apr. 09 Innovid Launches Harmony Initiative to Keep Tv Open for Everyone & Controlled by No One CI
Mar. 12 Innovid Corp. Announces Resignation of Rachel Lam from the Board of Directors and Member of Audit and Nominating and Corporate Governance Committees CI

Evolution of the average Target Price on Innovid Corp.

Price target over the last 5 years

History of analyst recommendation changes

242f3f90503bb20c0318.83S7ZCzuxG_XVY3pVoEuG81YQpglWHCOcttzfPPT5ng.3jmPMlWqmwOaOr2jOOZAVb87d81nMDn7OJ8HRICb1xe4B-kmZbmFPpJh_g~adb193d9d1e70e8a04add548ce57deb7

Analyst Recommendations on Innovid Corp.

Needham Adjusts Price Target on Innovid to $2.25 From $1.50, Maintains Buy Rating MT
Morgan Stanley Adjusts Innovid's Price Target to $1.50 From $1.40, Maintains Equalweight Rating MT
Needham Cuts Price Target on Innovid to $1.50 From $3, Keeps Buy Rating MT
Morgan Stanley Adjusts Innovid's Price Target to $1.40 From $1.10, Keeps Equalweight Rating MT
Morgan Stanley Adjusts Price Target on Innovid to $1.10 From $2.20, Maintains Equal-Weight Rating MT
Morgan Stanley Adjusts Innovid's Price Target to $2.20 From $2.40, Maintains Equal Wright Rating MT
JMP Securities Adjusts Price Target on Innovid to $5 From $6, Maintains Market Outperform Rating MT
Needham Adjusts Price Target on Innovid to $3 From $4, Maintains Buy Rating MT
Innovid Shares Plunge After Morgan Stanley Initiates Coverage MT
Morgan Stanley Initiates Innovid at Underweight with $2.70 Price Target MT
Morgan Stanley Starts Innovid at Underweight with $2.70 Price Target MT
JMP Securities Trims Innovid's Price Target to $6 From $9, Keeps Market Outperform Rating MT
Needham Adjusts Innovid's Price Target to $6 from $10, Maintains Buy Rating MT
BMO Capital Adjusts Innovid's Price Target to $8 from $13, Maintains Outperform Rating MT
JMP Securities Starts Innovid at Market Outperform With $11 Price Target MT
Needham Starts Innovid at Buy With $10 Price Target MT
BMO Capital Starts Innovid at Outperform With $13 Price Target MT
Evercore ISI Starts Innovid at Outperform With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
2.34 USD
Average target price
2.45 USD
Spread / Average Target
+4.70%
High Price Target
3 USD
Spread / Highest target
+28.21%
Low Price Target
2.1 USD
Spread / Lowest Target
-10.26%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Innovid Corp.

Needham & Co.
Morgan Stanley
JMP Securities
BMO Capital
Evercore ISI

Ratings for Innovid Corp.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CTV Stock
  4. Consensus Innovid Corp.